Intervention not reported
Adverse events-serious Mometasone/formoterol (MF/F) versus Mometasone (MF) · patients with COPD
The intervention showed no clear difference in adverse events-serious Mometasone/formoterol (MF/F) versus… (low certainty).
1 finding from 1 review
- Combined corticosteroid and long‐acting beta₂‐agonist in one inhaler versus inhaled corticosteroids alone for chronic… 2013 · Cochrane Headline outcomes onlyOR 1.03 [0.63, 1.67]2 studies · 905 participantsLow